跳至主要内容
临床试验/ISRCTN95766678
ISRCTN95766678已完成未知

Effect of a therapeutic strategy guided by lung ultrasound on 6-month outcomes in patients with heart failure. The EPICC trial

Sociedad Española de Medicina Interna0 个研究点目标入组 79 人开始时间: 2022年3月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
79

研究概览

简要总结

2019 Protocol article in https://doi.org/10.1007/s10557-019-06891-z (added 18/03/2022) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36013168/ results (added 05/04/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Age older than 18 y
  • 2. NYHA functional class =II at inclusion
  • 3. Able to attend ambulatory follow-up visits

排除标准

  • 1. Life expectancy <6 months due to a different medical condition than HF
  • 2. Heart transplantation
  • 3. Acute coronary syndrome
  • 4. Recent coronary revascularization
  • 5. Valve replacement or resynchronization in the prior 3 months
  • 6. Pregnancy
  • 7. Restrictive pulmonary disease or severe COPD needing continuous oxygen
  • 8. Serum creatinine >3 mg/dl or chronic renal insufficiency in dialysis
  • 9. Severe valve stenosis
  • 10. Participation in another randomized study

研究者

发起方
Sociedad Española de Medicina Interna

相似试验